4
Changes in Ownership
Tarsus Pharmaceuticals, Inc. Filed Acc 0001662426-25-000005
Director acquired 1,334 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Morrison Scott W Director | 2025-09-15 | Option exercise | +1,334 | 4,684 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Morrison Scott W Director | 2025-09-15 | Option exercise · Restricted Stock Units | −1,334 | 0 | D: show line 2 in the form |
Loading xslF345X05/wk-form4_1758053184.xml…